BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Life Raft Group - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://liferaftgroup.org
X-WR-CALDESC:Events for The Life Raft Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250711T140000
DTEND;TZID=America/New_York:20250711T140000
DTSTAMP:20250710T185244Z
CREATED:20250513T130002Z
LAST-MODIFIED:20250710T185244Z
UID:10000824-1752242400-1752242400@liferaftgroup.org
SUMMARY:GIST Awareness Day Fireside Chat
DESCRIPTION:July 13th\, GIST Awareness Day\, is a time when GIST experts\, patients\, and caregivers come together to educate the public about this disease and advocate for finding a cure.  The Life Raft Group invites GIST patients and caregivers to celebrate GIST Awareness Day with us on July 11th at 2PM ET. During this virtual event\, esteemed GIST experts Dr. Sicklick of UCSD and Dr. Blakely and Dr. John Glod of the NIH will answer patient and caregiver questions in an informal chat. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to srothschild@liferaftgroup.org. \nREGISTERAbout Our Presenters\n \nDr. Jason Sicklick\nUCSD\, Moores Cancer Center \nJason Sicklick\, MD\, is an internationally recognized surgical oncologist who specializes in treating gastrointestinal stromal tumors (GIST)\, abdominal/retroperitoneal sarcomas\, and liver tumors.He leader of the Sarcoma Disease Team and Co-leader of the Structural and Function Genomics Program at UC San Diego Health’s Moores Cancer Center. He is also a member of the National Comprehensive Cancer Network Soft-Tissue Sarcoma Committee and GIST Subcommittee\, which develops best practices for treating these rare and often challenging-to-treat cancers. \n \nDr. Andrew Blakely\nNational Cancer Institute (NCI) \nDr. Blakely completed a Bachelor of Science in Biomedical Engineering followed by medical school at Drexel University. He went on to general surgery residency at Brown University. During residency\, he spent two years of dedicated research time at the Center for Biomedical Engineering developing a device for tissue engineering applications. Dr. Blakely then completed his fellowship in Complex General Surgical Oncology at City of Hope National Medical Center. Dr. Blakely is currently a surgical oncologist specializing in peritoneal surface malignancies and soft tissue sarcomas. One of the primary focuses of his research includes improving surgical treatment and ex vivo tumor modeling of gastrointestinal stromal tumors. \n \nDr. John Glod\nNational Cancer Institute (NCI) \nDr. Glod obtained his M.D. and Ph.D. from the University of Colorado in Denver and trained in pediatrics and pediatric oncology at Cincinnati Children’s Hospital\, Johns Hopkins Hospital\, and the Pediatric Oncology Branch of the NCI.  Dr. Glod currently serves as the Clinical Director of the Pediatric Oncology Branch in the Center for Cancer Research at National Cancer Institute. Dr. Glod’s research interests are focused on early stage clinical trials for pediatric patients and rare pediatric solid tumors including multiple endocrine neoplasia-related medullary thyroid cancer\, SDH-deficient gastrointestinal stromal tumor\, and tumors of the central nervous system. \nThank You to Our Sponsors!\n 
URL:https://liferaftgroup.org/event/gad-fireside-chat/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250619T190000
DTEND;TZID=America/New_York:20250619T190000
DTSTAMP:20250515T204708Z
CREATED:20250513T131917Z
LAST-MODIFIED:20250515T204708Z
UID:10000823-1750359600-1750359600@liferaftgroup.org
SUMMARY:Updates from ASCO 2025
DESCRIPTION:ASCO (American Society of Clinical Oncology) is an important conference in the oncology community where new scientific research updates are shared. The Life Raft Group is excited to partner with Herbert Loong\, who will summarize abstracts and presentations that were presented during this conference that are relevant to the GIST patient community. Join us June 19th at 7pm for this virtual presentation. A Q&A session will follow the presentation. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to srothschild@liferaftgroup.org. \nREGISTERAbout Our Presenter\n \nDr. Herbert Loong \nThe Chinese University of Hong Kong \nDr. Herbert H. Loong holds conjoint appointments of Clinical Associate Professor in the Department of Clinical Oncology and Deputy Medical Director of the Phase 1 Clinical Trials Centre of The Chinese University of Hong Kong. He is also the current and founding convenor of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team. \nDr. Loong has served or continues to serve in various capacities in various professional international oncology bodies\, including the International Affairs Committee and the Asia-Pacific Regional Council of ASCO\, the Membership\, Education and Communications Committees of the IASLC. He has been elected as a Board Member of the Connective Tissue Oncology Society (CTOS) for 2022-2024. He is also a founding executive committee member of the newly formed Asia Pacific Oncology Drug Development Network (APODDC). He is also a Board Member in the specialty of Medical Oncology in the Hong Kong College of Physicians. In his appointment as a Registration Committee member of Pharmacy and Poisons Board of Hong Kong\, he helps oversee the registration of medicinal products and clinical trials in the territory. \nThank You to Our Sponsors!
URL:https://liferaftgroup.org/event/updates-asco-2025/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250513T120000
DTEND;TZID=America/New_York:20250513T120000
DTSTAMP:20250402T180059Z
CREATED:20250331T190351Z
LAST-MODIFIED:20250402T180059Z
UID:10000816-1747137600-1747137600@liferaftgroup.org
SUMMARY:Holistic Approaches to Healing
DESCRIPTION:The Life Raft Group is partnering with Certified Wellness Coach & Patient Advocate Carolina Williams to present\, “Holistic Approaches to Healing in Harmony”\, on May 13th at 12PM ET. This virtual session will blend mindfulness practices with vibrational living to support cancer patients and their caregivers in navigating the emotional and energetic challenges of healing. Through guided meditations\, breathwork\, and energy-awareness techniques\, participants will learn how to cultivate inner peace\, resilience\, and a healing mindset. Discover how vibrational frequencies influence well-being\, how to shift energy for emotional balance\, and how to create a supportive environment that fosters deep healing for both patients and caregivers. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to srothschild@liferaftgroup.org. \nREGISTERAbout Our Presenter\n \nCarolina Williams\nCertified Wellness Coach & Patient Advocate \nAfter facing Gastrointestinal Stromal Tumor (GIST)\, Carolina experienced an instantaneous remission—a profound moment that reinforced the power of mindfulness\, energy healing\, and vibrational living. While her healing journey included deep spiritual work\, meditation\, and energy alignment\, she also acknowledges the role of Gleevec\, the targeted therapy that supported her recovery. This integrative approach—combining science and vibrational medicine—became the foundation of her work. \nNow a certified Wellness Coach\, Reiki Master\, and Bio-Well Energy Field Practitioner\, Carolina is passionate about guiding cancer patients and caregivers toward inner peace\, resilience\, and healing. She teaches practical tools that support both emotional and physical well-being\, helping others navigate their journeys with greater strength\, hope\, and balance. \nThank You to Our Sponsors!
URL:https://liferaftgroup.org/event/holistic-approaches-to-healing/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250506T150000
DTEND;TZID=America/New_York:20250506T150000
DTSTAMP:20250403T201911Z
CREATED:20250402T184153Z
LAST-MODIFIED:20250403T201911Z
UID:10000818-1746543600-1746543600@liferaftgroup.org
SUMMARY:Los beneficios de los cuidados paliativos
DESCRIPTION:The Life Raft Group\, junto con Olivia Tigre-Nerimora de Stanford Health Care\, presentará el webinar: “Vive tu vida al máximo: Los beneficios de los cuidados paliativos”\, que se llevará a cabo el 6 de mayo a las 3 p. m. (hora del este). En esta sesión virtual\, la Sra. Tigre-Nerimora compartirá estrategias para vivir plenamente con un enfoque holístico y personalizado\, centrado en el bienestar integral. Además\, abordará aspectos clave como el manejo de síntomas físicos\, el bienestar emocional y el cuidado espiritual. También aprenderá sobre los cuidados paliativos y cómo esta especialidad médica puede brindarle apoyo para mejorar su calidad de vida. Al finalizar la presentación\, habrá una sesión de preguntas y respuestas.  \nEstos webinars son solo con fines informativos y no deben reemplazar el consejo médico profesional. Siempre consulte a su proveedor de atención médica antes de realizar cualquier cambio en su tratamiento o estilo de vida. Si tiene preguntas o comentarios\, por favor comuníquese con srothschild@liferaftgroup.org. \nREGISTRATEAcerca de Nuestra Presentadora\n \nOlivia Tigre-Nerimora\, MHA\nGerente de Proyectos\, Centro de Excelencia en Cuidados Paliativos \nOlivia Tigre Nerimora se desempeña actualmente como Gerente de Proyectos para el Centro de Excelencia en Cuidados Paliativos\, Olivia supervisa proyectos destinados a promover la educación y la concientización sobre los cuidados paliativos especializados. Sus esfuerzos enfatizan el aumento de la participación comunitaria\, particularmente entre las poblacionbes mas vulnerasbles\, para garantizar el acceso equitativo y la comprensión de los servicios de cuidados paliativos. \nGracias a Nuestros Patrocinadores!
URL:https://liferaftgroup.org/event/beneficios-de-los-cuidados-paliativos/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250506T140000
DTEND;TZID=America/New_York:20250506T140000
DTSTAMP:20250402T184138Z
CREATED:20250402T184138Z
LAST-MODIFIED:20250402T184138Z
UID:10000817-1746540000-1746540000@liferaftgroup.org
SUMMARY:The Benefits of Palliative Care
DESCRIPTION:The Life Raft Group is partnering with Dr. Grant Smith of Stanford Health Care to present “Live Your Best Life – The Benefits of Palliative Care” on May 6th at 2PM ET. During this virtual presentation\, Dr. Smith will share ways to live your best life using a holistic\, person-centered approach. During this workshop\, Dr. Smith will talk about physical symptoms as well as emotional and spiritual well-being. You’ll also learn about the medical specialty\, called palliative care\, and how it can give you an extra level of support and improve your quality of life. A question and answer session will follow the presentation. \nThese webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to srothschild@liferaftgroup.org. \nREGISTERAbout Our Presenter\n \nDr. Grant Smith\nCare Physician & Clinical Associate Professor of Medicine \nGrant Smith\, MD is a palliative care physician and Clinical Associate Professor of Medicine at the Stanford School of Medicine. He is the medical director of the Stanford Palliative Care Community Partnerships Team. He received his medical degree from Harvard Medical School and completed his residency in internal medicine and fellowship in hospice and palliative medicine at the University of California\, San Francisco. As part of the Stanford faculty\, he is an attending physician on the palliative care inpatient service and in the outpatient palliative care clinic in Palo Alto. \nThank You to Our Sponsors!
URL:https://liferaftgroup.org/event/benefits-of-palliative-care/
CATEGORIES:Education,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250328T160000
DTEND;TZID=America/New_York:20250328T160000
DTSTAMP:20250721T171401Z
CREATED:20250304T170951Z
LAST-MODIFIED:20250721T171401Z
UID:10000812-1743177600-1743177600@liferaftgroup.org
SUMMARY:Nutrición después de la cirugía de GIST
DESCRIPTION:The Life Raft Group se ha asociado con María Camila Gómez\, paciente y defensora de GIST\, así como estudiante de Nutrición\, para presentar “Nutrición después de la cirugía de GIST” el 28 de marzo a las 4 PM ET. En esta presentación\, María Camila abordará la nutrición después de una gastrectomía total o parcial\, combinando su experiencia personal como paciente con los conocimientos adquiridos durante sus últimos tres años de estudio en nutrición. Al finalizar la presentación\, habrá una sesión de preguntas y respuestas. Si tiene preguntas o comentarios\, póngase en contacto con srothschild@liferaftgroup.org. \nREGISTRATEBiografía de la Ponente:\n \nMaría Camila Gómez\nDefensora GIST & Estudiante de Nutrición \nMaría Camila Gómez ha sido paciente de GIST desde los 16 años y actualmente es estudiante de sexto semestre de Nutrición y Dietética. Hace cinco años\, tras someterse a una gastrectomía total\, reconoció el papel fundamental de la nutrición en la salud. Esta experiencia la llevó a estudiar nutrición\, tanto para comprender mejor su nueva realidad como para apoyar a otras personas que enfrentan desafíos similares. Además de su formación académica\, María Camila crea contenido en redes sociales para generar conciencia sobre la vida sin estómago y la importancia de una nutrición adaptada. \nGracias a Nuestros Patrocinadores!
URL:https://liferaftgroup.org/event/nutricion-despues-de-la-cirugia-de-gist/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250328T150000
DTEND;TZID=America/New_York:20250328T150000
DTSTAMP:20250721T171332Z
CREATED:20250304T170959Z
LAST-MODIFIED:20250721T171332Z
UID:10000811-1743174000-1743174000@liferaftgroup.org
SUMMARY:Nutrition After GIST Surgery
DESCRIPTION:The Life Raft Group is partnering with María Camila Gomez\, GIST Patient Advocate and Nutrition student\, to present “Nutrition After GIST Surgery” on March 28 at 3PM ET. Ms. Gomez will address nutrition needs after a total or partial gastrectomy\, blending her personal experience as a patient with what she has learned over the past three years of studying nutrition. A question and answer session will follow the presentation. \nThis webinar will be available on our YouTube channel—subscribe for updates on new GIST education videos. These webinars are for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before making any treatment or lifestyle changes. If you have questions or comments\, please reach out to srothschild@liferaftgroup.org. \nREGISTERAbout Our Presenter\n \nMaría Camila Gómez\nGIST Advocate & Nutrition Student \nMaría Camila Gomez has been a GIST patient since the age of 16 and is currently a sixth-semester Nutrition and Dietetics student. Five years ago\, after undergoing a total gastrectomy\, she recognized the vital role of nutrition in overall health. This realization led her to pursue studies in nutrition\, both to better understand her new reality and to support others facing similar challenges. In addition to her academic journey\, María Camila creates social media content to raise awareness about life without a stomach and the importance of adapted nutrition. \nThank You to Our Webinar Sponsors!
URL:https://liferaftgroup.org/event/nutrition-after-gist-surgery/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250108T143000
DTEND;TZID=America/New_York:20250108T143000
DTSTAMP:20241202T201549Z
CREATED:20241202T195947Z
LAST-MODIFIED:20241202T201549Z
UID:10000808-1736346600-1736346600@liferaftgroup.org
SUMMARY:Exploring The SARC044 Trial
DESCRIPTION:The Life Raft Group invites you to “Exploring The SARC044 Trial: Key Details & What The GIST Community Can Gain From The Study” on January 8th\, 2024 at 2:30PM ET. Dr. Candace Haddox\, Dana-Farber Cancer Institute\, will present an overview of the Phase II SARC044 Clinical Trial. This currently recruiting study tests the investigational use of bezuclastinib in combination with sunitinib in patients with GIST. Webinar participants will learn about the SARC044 study\, including eligibility\, site locations\, and study rationale. A Q&A session will follow the presentation. \nREGISTERAbout Our Presenter\n \nDr. Candace Haddox\nDana-Farber Cancer Institute \nDr. Candace Haddox is an Instructor in Medicine at Harvard Medical School\, and a medical oncologist and clinical/translational investigator in the Sarcoma Center and the Center for Cancer Therapeutic Innovation at Dana-Farber Cancer Institute. Dr. Haddox’s research focuses on developing novel therapies rooted in sarcoma biology and determining mechanisms of treatment response and resistance\, particularly in gastrointestinal stromal tumors (GIST). \nDr. Haddox received her Bachelor of Science in neurobiology from the University of Miami. She completed a post-baccalaureate research fellowship at the National Institutes of Health and received her Medical Degree from the University of South Florida. Dr. Haddox completed a residency in Internal Medicine at the Mayo Clinic in Rochester\, Minnesota\, and a fellowship in Medical Oncology at Duke University\, where she also served as Chief Fellow. She joined the faculty at Dana-Farber Cancer Institute in 2021\, where she currently sees patients with sarcomas and leads clinical trials in early drug development.
URL:https://liferaftgroup.org/event/exploring-the-sarc044-trial/
CATEGORIES:Education,Events,Webcast
ATTACH;FMTTYPE=image/jpeg:https://liferaftgroup.org/wp-content/uploads/2024/12/SARC-Webinar.jpg
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241125T120000
DTEND;TZID=America/New_York:20241125T120000
DTSTAMP:20241120T145456Z
CREATED:20241009T202805Z
LAST-MODIFIED:20241120T145456Z
UID:10000795-1732536000-1732536000@liferaftgroup.org
SUMMARY:Updates from CTOS
DESCRIPTION:The Life Raft Group is partnering with Dr. Thierry Alcindor of Dana-Farber Cancer Institute to present “GIST Updates from CTOS 2024” to GIST patients and caregivers on November 25th at 12pm ET. During this virtual presentation\, Dr. Alcindor will discuss scientific updates relevant to GIST patients that were exhibited at the Connective Tissue Oncology Society (CTOS) conference. A Q&A segment followed Dr. Alcindor’s presentation. \n\nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\n \nDr. Thierry Alcindor\nDana-Farber Cancer Institute \nDr. Alcindor earned his medical degree at the State University of Haiti and a Master of Science degree at the University of Oxford. He trained in Internal Medicine and Hematology/Oncology at Yale-New Haven Medical Center and Tufts-New England Medical Center\, respectively. Previously at McGill University\, he is now a Senior Physician and medical oncologist at the Dana-Farber Cancer Institute\, affiliated with Harvard Medical School. His interests cover treatment and investigation of sarcomas\, including gastro-intestinal stromal tumors (GIST). \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/updates-from-ctos/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241106T130000
DTEND;TZID=America/New_York:20241106T130000
DTSTAMP:20241107T135829Z
CREATED:20241009T190246Z
LAST-MODIFIED:20241107T135829Z
UID:10000794-1730898000-1730898000@liferaftgroup.org
SUMMARY:Know Your Mutation:  Why is Biomarker Testing Important in GIST?
DESCRIPTION:The Life Raft Group invites you to “Know Your Mutation: Why is Biomarker Testing Important in GIST?”\, on November 6th\, 2024 at 1PM ET. During this educational webinar\, Michelle Harris and Calvin Chao of Tempus will discuss the importance of biomarker testing in GIST\, the process of biomarker testing\, how to get testing done for free through the LRG\, and more. A Q&A session will follow the presentation. \n\nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenters\n \nDr. Calvin Chao\nSenior Vice President of Medical Affairs\, Tempus \nPreviously\, Dr. Chao spent thirteen years leading studies and education for the Oncotype DX Breast\, Prostate\, and Colon Cancer assays at Genomic Health\, later acquired by Exact Sciences.  Prior to that role\, he worked in various bio-pharmaceutical medical director positions at Onyx Pharmaceuticals\, PDL BioPharma\, TAP Pharmaceuticals\, and SmithKline Beecham. \nIn his early career\, Dr. Chao practiced as a board-certified internist and hospitalist at Kaiser Permanente in California for ten years. He earned his MD from the University of Texas Medical Branch\, completed his medical residency at Presbyterian-St. Luke’s Medical Center in Denver\, Colorado\, received his MBA from St. Mary’s College\, California\, and his BS in Chemical Engineering from University of California\, Berkeley. \n \nMichelle Harris\nSenior Director Medical Affairs\, Tempus AI \nMichelle has worked in the oncology space for almost 20 years in research\, development and medical affairs.  She has been at Tempus AI for 2&1/2 years leading the field medical liaison team\, who work with physicians on research and education.  Prior to Tempus\, Michelle worked in solid tumor drug development and clinical trials at Novartis and Gilead Sciences. \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/know-your-mutation/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241007T130000
DTEND;TZID=America/New_York:20241007T130000
DTSTAMP:20240904T152915Z
CREATED:20240828T192519Z
LAST-MODIFIED:20240904T152915Z
UID:10000790-1728306000-1728306000@liferaftgroup.org
SUMMARY:IDRX-42: Trial Design & Emerging Data from StrateGIST 1
DESCRIPTION:The Life Raft Group invites you to “IDRX-42: Trial Design and Emerging Data from the StrateGIST 1 Study”\, on October 7th\, 2024 at 1PM ET. During this educational webinar\, Suzanne George\, MD of the Dana-Farber Cancer Institute will review emerging data from the first-in-human StrateGIST 1 trial of IDRX-42 in patients with advanced GIST. Dr. George will also discuss the design and rationale for the ongoing Phase 1b portion of the trial\, including first- and second-line cohorts. A Q&A session will follow the presentation. \n\nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\n \nDr. Suzanne George\nSarcoma Center at Dana-Farber Cancer Institute \nSuzanne George\, MD is the Division Chief of the Sarcoma Center at Dana-Farber Cancer Institute who leads a team focused on research and clinical care of patients with sarcomas and GIST. She has an extensive research experience in clinical trials and drug development and cares for patient from across New England\, the US and internationally. \nThank you to our Webinar Sponsor!
URL:https://liferaftgroup.org/event/idrx-42-trial-design-and-emerging-data-from-the-strategist1-study/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240909T120000
DTEND;TZID=America/New_York:20240909T120000
DTSTAMP:20240812T202409Z
CREATED:20240812T202329Z
LAST-MODIFIED:20240812T202409Z
UID:10000788-1725883200-1725883200@liferaftgroup.org
SUMMARY:Locoregional Therapies for Treatment of GIST in the Liver
DESCRIPTION:Interventional radiology is a medical specialty that performs various minimally-invasive procedures to treat cancer and other diseases. The Life Raft Group invites world-renowned interventional radiologist Edward Kim\, MD FSIR of Mount Sinai to present “Locoregional Therapies for Treatment of GIST in the Liver” on September 9th at 12pm ET. During this virtual presentation\, Dr. Kim will describe various locoregional therapies and their appropriate uses\, as well as the role of locoregional therapies and systemic therapy in treating GIST when it metastasizes in the liver. A Q&A portion will follow the presentation. \n\nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\n \nDr. Edward Kim\nMount Sinai Medical Center \nEdward Kim\, MD FSIR is Professor of Radiology and Surgery and Director of Interventional Oncology at Mount Sinai Health Systems\, under the Division of Interventional Radiology. He attended Rutgers Medical School and finished his Interventional Radiology training at Mount Sinai.  Dr. Kim is a world-renowned Interventional Radiologist\, who focuses on minimally invasive treatments\, known as locoregional therapies\, for the treatment of liver cancer.  He has authored numerous influential peer reviewed publications and runs multiple prospective clinical trials.  He has been invited to be course director and faculty at numerous meetings throughout the world.  He believes that best patient care is achieved through a multidisciplinary collaboration and helps lead the multidisciplinary tumor board at Mount Sinai\, as well as helped institute multidisciplinary office hours with liver transplant\, hepatology and surgery.  He is a thought leader in liver cancer\, especially with regards to radioembolization\, thermal ablation and chemoembolization\, as well as combination therapies with immune checkpoint inhibitors. \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/locoregional-therapies-for-treatment-of-gist-in-the-liver/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240819T120000
DTEND;TZID=America/New_York:20240819T120000
DTSTAMP:20240724T134516Z
CREATED:20240724T133110Z
LAST-MODIFIED:20240724T134516Z
UID:10000786-1724068800-1724068800@liferaftgroup.org
SUMMARY:Managing Side Effects of GIST Therapies
DESCRIPTION:The Life Raft Group has partnered with Mia Weiss\, MD of Washington University School of Medicine in St. Louis to present “Managing Side Effects of GIST Therapies” to GIST patients and caretakers on August 19\, 2024 at 12pm. During this virtual presentation\, Dr. Weiss will provide an overview of GIST treatments and their side effects as well as home management for each type of symptom and when to call the clinic. \n\n\nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\n \nDr. Mia Weiss\nWashington University School of Medicine in St. Louis \nMia C. Weiss\, M.D. is a medical oncologist with clinical interest in the care of patients with localized and metastatic soft tissue and bone sarcomas. She works collaboratively with pathologists\, radiation oncologists\, and orthopedic surgeons to assess\, diagnose\, and treat these complex malignancies. She is a member of the American College of Physicians\, the American Society of Clinical Oncology\, and the Connective Tissue Oncology Society. Her research interests include clinical trial development to assess efficacy of novel therapies in the treatment of metastatic sarcoma to ultimately improve patient survival and quality of life. She has particular interest related to genomics in sarcoma and finding ways to elucidate which patients are more likely to respond to targeted therapy and why some do not. Dr. Weiss has published several articles during her fellowship which most recently included a review on the use of Tazemetostat in epithelioid sarcoma\, a novel epigenetic regulator and the first of its kind to be approved in a solid tumor. Additionally\, Dr. Weiss has a strong interest in establishing a continuing medical educational program for community based primary care physicians and surgeons related to sarcoma and the importance of referring patients with soft tissue masses to an oncologic surgeon and ideally\, a sarcoma center\, to ensure optimal outcomes for patients. Dr. Weiss looks forward to continuing a career devoted to patient care\, research\, and education. \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/managing-side-effects-of-gist-therapies/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240712T120000
DTEND;TZID=America/New_York:20240712T120000
DTSTAMP:20250311T151017Z
CREATED:20240617T175754Z
LAST-MODIFIED:20250311T151017Z
UID:10000784-1720785600-1720785600@liferaftgroup.org
SUMMARY:GIST Awareness Day: A Focus on GIST Research
DESCRIPTION:July 13th\, GIST Awareness Day\, is a time when GIST experts\, patients\, and caregivers come together to educate the public about this disease and advocate for finding a cure.  The Life Raft Group invites GIST patients and caregivers to celebrate GIST Awareness Day with us on July 12th at 12PM ET. During this virtual event\, Dr. Matthew Hemming and PhD candidate Favour Akabogu of UMass Cancer Center will discuss exploring mechanisms driving GIST\, treatment efficacy\, and clinical outcomes\, as well as the importance of patient involvement in rare disease research. An interactive Q&A segment will follow their presentations. \n\nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenters\n \nDr. Matthew Hemming\nUMass Chan Medical School \nDr. Matthew Hemming  is an assistant professor of medicine at UMass Chan Medical School\, practicing sarcoma medical oncologist\, and principal investigator of the SarcomaLab. He received his BS from UC San Diego\, PhD from Harvard University\, and MD from Harvard Medical School. He completed internal medicine residency at Massachusetts General Hospital and Hematology/Oncology fellowship at Dana-Farber Cancer Institute. He has focused his clinical practice and laboratory work on sarcoma and GIST\, with the goal to improve diagnostic and treatment strategies through basic and translational research. \n \nFavour Akabogu\nPhD Candidate \nFavour Akabogu is a PhD candidate in the SarcomaLab through the Morningside Graduate School of Biomedical Sciences at UMass Chan Medical School where she studies gastrointestinal stromal tumors (GIST) with a focus on identifying novel treatment options. She got her B.A in Biology at Berea College in Kentucky and worked as a Research Associate at Vanderbilt University where she investigated the role of Discodain Domain Receptors (DDRs) in the progression of acute kidney injury to kidney fibrosis. Additionally\, she worked in collaboration with the CDC on understanding the household transmission respiratory disease particularly SARS-CoV2\, RSV and Influenza. She is passionate about healthcare and drug discovery through scientific innovation. She loves traveling\, dancing\, and spending time with family and friends in her free time. \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/gist-awareness-day-a-focus-on-gist-research/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240618T190000
DTEND;TZID=America/New_York:20240618T190000
DTSTAMP:20240422T182217Z
CREATED:20240422T181458Z
LAST-MODIFIED:20240422T182217Z
UID:10000773-1718737200-1718737200@liferaftgroup.org
SUMMARY:Updates from ASCO
DESCRIPTION:The American Society of Clinical Oncology (ASCO) is an important conference in the oncology community where new scientific research updates are shared. The Life Raft Group is excited to partner with Dr. Herbert Loong\, who will summarize abstracts and presentations that were presented during ASCO 2024 that are relevant to the GIST patient community. Join us June 18th at 7pm ET for this virtual presentation. A Q&A session will follow the presentation. \nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\n \nDr. Herbert H. Loong\nThe Chinese University of Hong Kong \nDr. Herbert H. Loong holds conjoint appointments of Clinical Associate Professor in the Department of Clinical Oncology and Deputy Medical Director of the Phase 1 Clinical Trials Centre of The Chinese University of Hong Kong. He is also the current and founding convenor of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team. \nDr. Loong has served or continues to serve in various capacities in various professional international oncology bodies\, including the International Affairs Committee and the Asia-Pacific Regional Council of ASCO\, the Membership\, Education and Communications Committees of the IASLC. He has been elected as a Board Member of the Connective Tissue Oncology Society (CTOS) for 2022-2024. He is also a founding executive committee member of the newly formed Asia Pacific Oncology Drug Development Network (APODDC). He is also a Board Member in the specialty of Medical Oncology in the Hong Kong College of Physicians. In his appointment as a Registration Committee member of Pharmacy and Poisons Board of Hong Kong\, he helps oversee the registration of medicinal products and clinical trials in the territory. \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/updates-asco-2024/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240522T110000
DTEND;TZID=America/New_York:20240522T110000
DTSTAMP:20240423T174622Z
CREATED:20240422T181945Z
LAST-MODIFIED:20240423T174622Z
UID:10000772-1716375600-1716375600@liferaftgroup.org
SUMMARY:Demystifying Clinical Trials
DESCRIPTION:Insights from Experts and Participants\nJoin us May 22nd at 11am ET for an informative webinar presented by Dr. Candace Haddox of Dana-Farber Cancer Institute offering invaluable insights into the world of clinical trials in honor of International Clinical Trials Awareness Day. Dr. Haddox will delve into the fundamentals of clinical trials\, discussing their significance\, weighing the pros and cons of participation\, and guiding attendees through the entire process\, from initiation to conclusion. Following Dr. Haddox’s presentation\, there will be an interactive discussion with GISTer Kandee Evans\, currently enrolled in a clinical trial\, offering firsthand experiences and perspectives. A Q&A session will follow the presentation. \nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenters\n \nDr. Candace Haddox \nDana-Farber Cancer Institute \nDr. Haddox is an Instructor in Medicine at Harvard Medical School\, and a medical oncologist and clinical/translational investigator in the Sarcoma Center and the Center for Cancer Therapeutic Innovation at Dana-Farber Cancer Institute. Dr. Haddox’s research focuses on developing novel therapies rooted in sarcoma biology and determining mechanisms of treatment response and resistance\, particularly in gastrointestinal stromal tumors (GIST). \nDr. Haddox received her Bachelor of Science in neurobiology from the University of Miami. She completed a post-baccalaureate research fellowship at the National Institutes of Health and received her Medical Degree from the University of South Florida. Dr. Haddox completed a residency in Internal Medicine at the Mayo Clinic in Rochester\, Minnesota\, and a fellowship in Medical Oncology at Duke University\, where she also served as Chief Fellow. She joined the faculty at Dana-Farber Cancer Institute in 2021\, where she currently sees patients with sarcomas and leads clinical trials in early drug development. \n \nKandee Evans \nGIST Advocate \nWith a career spanning over three decades\, Kandee Evans is a project management veteran who knows how to make things happen. After dedicating 30 years to her profession\, Kandee recently left her job to focus on her health as a GIST survivor and warrior. Not one to back down from a challenge\, she previously advocated fiercely for her oldest son when he was diagnosed with autism at just two years old. Now\, as a devoted wife and mother of two amazing sons\, Kandee continues to take on each day with grace\, courage\, and determination. \nAt the forefront of GIST research\, Kandee is making a difference through participation. She enrolled in a clinical trial with the University of Miami in February 2024\, she is helping test the effects of IDRX-42 under the direction of Dr. Jonathan Trent.  Her selfless commitment will provide key insights and move science one step closer to finding a treatment for this devastating disease. Kandee’s courage underscores the power of individuals to advance medical progress through clinical trial involvement. \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/demystifying-clinical-trials-insights-from-experts-and-participants/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240430T120000
DTEND;TZID=America/New_York:20240430T120000
DTSTAMP:20240403T191818Z
CREATED:20240403T191818Z
LAST-MODIFIED:20240403T191818Z
UID:10000771-1714478400-1714478400@liferaftgroup.org
SUMMARY:Educate Yourself on GIST Research
DESCRIPTION:How to Educate Yourself on GIST Research – Searching the Web for GIST Science Publications\nLife Raft Group Science Team Member Jim Hughes will present “How to Educate Yourself on GIST Research- Searching the Web for GIST Science Publications” to GIST patients & caregivers on April 30th\, 2024 at 12pm ET. During this virtual presentation\, Jim will outline the importance of patients and caregivers researching their cancer in order to best advocate for themselves. Jim will explain the importance of GIST publications and how to effectively do your own research\, and how to work together with fellow community members to share research findings. \nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\n \nJim Hughes\nLRG Clinical Trials Database Coordinator/Science Team Member \nJim Hughes attended Kenyon College\, Ohio and Loyola University\, Chicago where he earned a BA in Philosophy. Between schools Jim served as an officer in the United States Army in the US and Vietnam and following his service worked in telecommunications for 35 years. \nJim and Margi are the parents of two children\, Nancy and Jamie. Nancy Hughes Welsh was an early member of The Life Raft Group (2002). Nancy was diagnosed with leiomyosarcoma in 1991 at age 23. After ten years of surgery and chemotherapy Nancy was re-diagnosed with GIST in 2001. Nancy participated in the Phase Three imatinib trial in 2001 and the Phase Two sunitinib trial in 2003. Nancy’s GIST was eventually diagnosed as SDH epimutant and passed away in 2005. \nJim serves as a Life Raft Group Board Member\, our Clinical Trials Database Coordinator and is a founding member of the LRG Science Team. \n  \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/educate-yourself-on-gist-research/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240411T120000
DTEND;TZID=America/New_York:20240411T120000
DTSTAMP:20240403T190917Z
CREATED:20240313T180524Z
LAST-MODIFIED:20240403T190917Z
UID:10000770-1712836800-1712836800@liferaftgroup.org
SUMMARY:Gaining Insight on the INSIGHT Phase 3 Study
DESCRIPTION:The Life Raft Group is partnering with Dr. Neeta Somaiah of MD Anderson Cancer Center to host "Gaining Insight on the Phase 3 INSIGHT Clinical Trial" for the GIST community on April 11th\, 2024 from 12-1:15 pm ET. During the webinar\, Dr. Somaiah will present an overview of Deciphera Pharmaceutical's Phase 3 INSIGHT Clinical Trial. This study tests the investigational use of ripretinib in a subset of patients living with GIST. Webinar participants will learn about the INSIGHT study\, including eligibility\, site locations\, and study rationale. A Q & A session will follow the presentation.    \nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\n\nPlease note that this webinar is not a substitute for your physician's guidance and care.\nREGISTERAbout Our Presenter\nNeeta Somaiah\, MD\nMD Anderson Cancer Center \nDr. Neeta Somaiah received her medical degree from Maulana Azad Medical College in New Delhi\, India and has trained at St. John’s Episcopal in New York\, Drexel University Hospital and Fox Chase Cancer Center in Philadelphia\, prior to joining MD Anderson Cancer Center.  \nDr. Somaiah joined MD Anderson Cancer Center in 2012.  She has thirteen years of sarcoma and clinical research experience. She is board certified in Medical Oncology.  Her primary clinical and research focus is soft tissue sarcomas\, specifically liposarcomas and GIST.  She currently serves as the Principal Investigator of three investigator-initiated trials and nine cooperative group and industry-sponsored clinical trials at MD Anderson Cancer Center and has in depth knowledge with extensive experience in the design and execution of clinical trials. She also has multiple ongoing collaborations for translational research\, both retrospective and prospective\, that help improve the understanding of these rare group of diseases and explore the role of immunotherapy as a therapeutic avenue.  Dr. Somaiah has been presented many honors for her expertise and contributions to science\, including an Exceptional Women in Medicine award and is among the top 1% providers nationally.   \nThank you to our Webinar Sponsor!
URL:https://liferaftgroup.org/event/gaining-insight-on-the-insight-phase-3-study/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231207T130000
DTEND;TZID=America/New_York:20231207T130000
DTSTAMP:20231116T164647Z
CREATED:20231116T164425Z
LAST-MODIFIED:20231116T164647Z
UID:10000633-1701954000-1701954000@liferaftgroup.org
SUMMARY:Matching Biomarkers to Disease Biology & Therapy
DESCRIPTION:The Life Raft Group is partnering with Dr. Jason Sicklick of UC San Diego Health’s Moores Cancer Center to present “Matching Biomarker to Biology and Therapy” for the GIST community on December 7th\, 2023 at 1:00 PM ET. During this virtual presentation\, Dr. Sicklick will discuss the importance of biomarker testing and research that correlates the biology of GIST with treatment. A Q&A session will follow the presentations. \nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenters\nDr. Jason Sicklick\nMoores Cancer Center\, US San Diego Health \nDr. Sicklick is an internationally recognized surgical oncologist who specializes in treating gastrointestinal stromal tumors (GIST)\, abdominal/retroperitoneal sarcomas\, and liver tumors. \nHe is a champion of innovation and collaboration to improve outcomes for cancer patients. He leader of the Sarcoma Disease Team and Co-leader of the Structural and Function Genomics Program at UC San Diego Health’s Moores Cancer Center. Dr. Sicklick is also a member of the National Comprehensive Cancer Network Soft-Tissue Sarcoma Committee and GIST Subcommittee\, which develops best practices for treating these rare and often challenging-to-treat cancers. \nAs professor of surgery and pharmacology at UC San Diego School of Medicine\, Dr. Sicklick conducts basic\, translational and clinical research to improve our understanding of GIST\, as well as to enhance precision medicine approaches for treating metastatic cancers. His laboratory focuses on the molecular mechanisms of GIST development and drug resistance. \nThank you to our 2023 Webinar Sponsors!
URL:https://liferaftgroup.org/event/matching-biomarkers-to-disease/
CATEGORIES:Education,Events
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231127T170000
DTEND;TZID=America/New_York:20231127T170000
DTSTAMP:20231106T143542Z
CREATED:20231031T133024Z
LAST-MODIFIED:20231106T143542Z
UID:10000632-1701104400-1701104400@liferaftgroup.org
SUMMARY:GIST Updates from CTOS
DESCRIPTION:The Life Raft Group is partnering with Dr. Herbert Loong of the Chinese University of Hong Kong to present “GIST Updates from CTOS 2023” to GIST patients and caregivers on November 27th at 5pm ET. During this virtual presentation\, Dr. Loong will discuss scientific updates relevant to GIST patients that were exhibited at the Connective Tissue Oncology Society (CTOS) conference. A Q&A segment will follow Dr. Loong’s presentation. \nREGISTERAbout Our Presenter\nHerbert H. Loong\, MD\nThe Chinese University of Hong Kong \nDr. Herbert H. Loong holds conjoint appointments of Clinical Associate Professor in the Department of Clinical Oncology and Deputy Medical Director of the Phase 1 Clinical Trials Centre of The Chinese University of Hong Kong. He is also the current and founding convenor of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team. \nDr. Loong obtained his medical degree with a Distinction in Surgery from The University of Hong Kong in 2003. He has completed a Fellowship in Drug Development at Princess Margaret Cancer Centre in Toronto\, Canada with a special focus on Experimental Therapeutics. His clinical and research interests also include Sarcoma Medical Oncology\, Thoracic Oncology and Health Economics. He is a recipient of the European Cancer Congress Fellowship Grant (2013)\, the American Society of Clinical Oncology (ASCO) Annual Meeting Merit Award (2014)\, the Hong Kong College of Physicians Young Investigators’ Award (2014). Nominated by patients and their caregivers\, Dr. Loong led the Lung Cancer Team at CUHK to be bestowed the IASLC Foundation Cancer Care Team Award in recognition for providing the best thoracic oncology care in “Asia & Rest of the World” in 2018. \nDr. Loong has served or continues to serve in various capacities in various professional international oncology bodies\, including the International Affairs Committee and the Asia-Pacific Regional Council of ASCO\, the Membership\, Education and Communications Committees of the IASLC. He has been elected as a Board Member of the Connective Tissue Oncology Society (CTOS) for 2022-2024. He is also a founding executive committee member of the newly formed Asia Pacific Oncology Drug Development Network (APODDC). He is also a Board Member in the specialty of Medical Oncology in the Hong Kong College of Physicians. In his appointment as a Registration Committee member of Pharmacy and Poisons Board of Hong Kong\, he helps oversee the registration of medicinal products and clinical trials in the territory. \nThank you to our 2023 Webinar Sponsors!
URL:https://liferaftgroup.org/event/gist-updates-from-ctos/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231012T110000
DTEND;TZID=America/New_York:20231012T110000
DTSTAMP:20230804T192657Z
CREATED:20230804T192657Z
LAST-MODIFIED:20230804T192657Z
UID:10000626-1697108400-1697108400@liferaftgroup.org
SUMMARY:Understanding GIST & Desmoid Tumors
DESCRIPTION:The Life Raft Group is partnering with Dr. Jonathan Trent and Dr. Steven Bialick of Sylvester Comprehensive Cancer Center to present “Understanding GIST and Desmoids” for the GIST/Desmoid community on October 12th\, 2023 at 11AM ET. During this virtual presentation\, Dr. Trent and Dr. Bialick will discuss GIST and desmoid tumors to keep pace with the ever-growing body of knowledge about these disease groups\, and the development of new tools and strategies to support this patient and caregiver community. A Q&A session will follow the presentations. \nREGISTERAbout Our Presenters\nDr. Jonathan Trent\nSylvester Comprehensive Cancer Center \nJonathan C. Trent\, MD\, PhD is currently the Associate Director for Clinical Research\, the Director of the Bone and Soft-tissue Sarcoma Group at the Sylvester Comprehensive Cancer Center. Dr. Trent’s interests are in the clinical and translational research of sarcomas\, direct care of sarcoma patients\, and education about sarcoma. \n\nDr. Steven Bialick\nSylvester Comprehensive Cancer Center \nSteven Bialick\, DO\, MS is a recent graduate of the hematology/oncology fellowship program at the University of Miami/Jackson Memorial Hospital. He is a medical oncologist specializing in the care of patients with sarcoma and gastrointestinal malignancies at the Sylvester Comprehensive Cancer Center in South Florida. Dr. Bialick has a particular clinical research interest in connective tissue cancers and the role of circulating tumor DNA in solid tumor oncology. \n\nThank you to the sponsor of this webinar:
URL:https://liferaftgroup.org/event/understanding-gist-desmoid-tumors/
CATEGORIES:Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230928T120000
DTEND;TZID=America/New_York:20230928T120000
DTSTAMP:20230822T183247Z
CREATED:20230817T122902Z
LAST-MODIFIED:20230822T183247Z
UID:10000629-1695902400-1695902400@liferaftgroup.org
SUMMARY:Advocating for Yourself or a Loved One with GIST
DESCRIPTION:Santy DiSabatino\, Director of our US GIST Mentor Program\, will be chatting with a group of GIST patients who have extensive experience advocating for themselves and their loved ones for the best possible care. We are grateful to these individuals who have been so inspirational and thankful that they are willing to join us on September 28th at noon ET to share how to navigate the medical space to ensure that you receive the highest quality of life possible for you or your loved one. \nREGISTERAbout Our Presenter\nSanty DiSabatino\nDirector\, US GIST Mentor Program \nSanty DiSabatino has been very active in our LRG community as a volunteer\, serving currently as the Voluntary Director of the GIST Mentor program\, and as a mentor. \n\nOur Featured Guest Panel\n\nIan Seah \nIan Seah is an extremely active GIST patient originally from Singapore and who now resides in New York City. He has various interests that have led him to career opportunities in tech\, crypto\, snack foods and yoga. Since being diagnosed with GIST\, he has continued his diverse career ventures and now enjoys new hobbies such as photography and cooking. Ian has taken part in two GIST clinical trials at Memorial Sloan Kettering and has traveled to Europe for integrative treatment options in his journey to be cancer free. Ian is a great example of someone who has tirelessly advocated for himself to receive the best possible outcomes. \n\nMargaret McInteer\nMargaret McInteer is a loving wife\, mother\, grandmother\, and great grandmother who has worked over fifty years in education. After being diagnosed with GIST in 2019\, Margaret connected with The Life Raft Group and is grateful to have been connected with a wonderful mentor who helped her navigate her disease journey to ensure the highest quality of life. Margaret recounts that being diagnosed with GIST forced her to slow down\, take care of herself\, and pay attention to the important things. She feels her life is even richer now and more fulfilling. \n\n  \nJean and Gary Erion`\nJean and Gary Erion are a married couple who both live with GIST. Gary is retired from the social work/counseling space and Jean currently works in the Assisted Living sector providing direct care. Jean and Gary enjoy long walks and spending quality time with their loved ones. Throughout their GIST journey\, Jean and Gary have advocated for themselves and each other\, gaining valuable self-advocacy experience. \nThank you to our 2023 Webinar Sponsors!
URL:https://liferaftgroup.org/event/advocating-for-yourself-and-loved-ones/
CATEGORIES:Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230918T120000
DTEND;TZID=America/New_York:20230918T120000
DTSTAMP:20230822T183423Z
CREATED:20230721T225845Z
LAST-MODIFIED:20230822T183423Z
UID:10000567-1695038400-1695038400@liferaftgroup.org
SUMMARY:Getting the GIST of It: How to Manage Side Effects of GIST Therapies
DESCRIPTION:The Life Raft Group has partnered with Emmeline C. Academia\, PharmD\, BCOP of Beth Israel Deaconess Medical Center to present “Getting the GIST of it: How to Manage Side Effects of GIST Therapies” for GIST patients and caretakers on September 18th\, 2023 at 12pm. During this virtual presentation\, Ms. Academia will provide an overview of GIST treatments and their side effects as well as home management for each type of symptom and when to call the clinic. \nREGISTERAbout Our Presenter:\nEmmeline C. Academia\, PharmD\, BCOP \nBeth Israel Deaconess Medical Center \nMs. Academia is a practicing clinical pharmacy specialist in adult oncology at Beth Israel Deaconess Medical Center in Boston. She is board certified in oncology\, and sub-specializes in gastrointestinal and thoracic malignancies\, along with sarcoma. She precepts students from Northeastern University and the Massachusetts College of Pharmacy and Health Sciences. She is a contributing editor for MET Crusaders\, a nonprofit organization dedicated to patients with MET alterations. She also reviews and writes for GoodRx\, focusing on oncology-related medications and topics\, and is the co-author of several published journal articles. Dr. Academia received her Doctor of Pharmacy degree from the University of California\, San Francisco before completing 2 years of pharmacy residency at the University of Colorado in general pharmacy practice\, followed by specialized training in adult oncology. \nThank you to our 2023 Webinar Sponsors!
URL:https://liferaftgroup.org/event/manage-side-effects/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230713T120000
DTEND;TZID=America/New_York:20230713T131500
DTSTAMP:20230706T163000Z
CREATED:20230601T184055Z
LAST-MODIFIED:20230706T163000Z
UID:10000565-1689249600-1689254100@liferaftgroup.org
SUMMARY:GIST Awareness Day 2023
DESCRIPTION:July 13th\, GIST Awareness Day\, is a time where GIST experts\, patients\, caregivers can come together to educate the public about this disease and advocate towards finding a cure. The Life Raft Group invites GIST patients and caregivers to celebrate GIST Awareness Day with us on July 13th from noon to 1:15pm ET. During this virtual event\, Dr. Jason Sicklick of UC San Diego Health\, Dr. John Glod of the National Cancer Institute\, and Dr. Venkata Ramesh Bulusu of Cambridge University Hospital will discuss GIST research updates. An interactive Q&A segment will follow their presentations. \nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenters\nDr. Ramesh Bulusu\nCambridge University Hospitals \nDr. Ramesh Bulusu has trained at the Beatson Oncology Centre\, Glasgow\, Addenbrooke’s Hospital\, Cambridge and Churchill hospital\, Oxford\, before taking up his consultant position in Addenbrooke’s hospital in Cambridge in 2002.Dr Bulusu is the founder/chairman of the Cambridge Gastrointestinal Stromal Tumour (GIST) Study Group and the network lead for GISTs in Cambridge. He has served as the Track leader and member of the Sarcoma Track of the American Society of Clinical Oncology Scientific Committee from 2013-2017. \nDr Bulusu is passionate about GISTs and is currently heading a national focus group PAWS-GIST (paediatric\, adolescent\, wild type and syndromic).In 2014\, he has established a national clinic in Cambridge for PAWS-GIST to facilitate research in this rare subgroup of GISTs.\nHe is actively involved in the training and education of health care professionals in the management of GISTs and has presented and lectured extensively\, both nationally and internationally. He has co-authored the UK GIST guidelines in 2004\, 2009 and 2017. \nDr. John Glod\nNIH Center for Cancer Research\, National Cancer  \nAs a member of the Pharmacology and Experimental Therapeutics section of the NCI Pediatric Oncology Branch\, Dr. Glod’s research program focuses broadly on developing new therapies for the treatment of pediatric cancer patients with a focus on rare solid tumors. Dr. Glod has expertise in the management and treatment of patients with rare tumor predisposition syndromes including multiple endocrine neoplasia type 2B and germline succinate dehydrogenase deficiency. He is the NCI principal investigator (PI) for a natural history study of patients with MEN2B and a single institution study of guadecitabine in SDH-deficient GIST\, paraganglioma\, and renal cell cancer as well as other early phase studies in pediatric oncology. \nDr. Jason Sicklick\nMoores Cancer Center\, US San Diego Health \nis an NIH-funded investigator and Associate Professor of Surgery at the University of California San Diego Moores Cancer Center. He is a board-certified general surgeon and surgical oncologist specializing in the treatment of hepatobiliary diseases and sarcomas\, including gastrointestinal stromal tumors (GIST). In 2016\, Dr. Sicklick was named the GIST Clinician of the Year by the Life Raft GIST Support Group\, the largest GIST patient advocacy group in the world. In 2018\, Dr. Sicklick was selected as a James IV Association of Surgeons fellow. This highly prestigious international traveling fellowship is designed to promote communication and collaboration in the surgical community. In 2018 he also received the RARE Champion of Hope in Medical Care & Treatment Award from the Global Genes-Allies in Rare Disease. He obtained his medical degree from the UCLA School of Medicine\, completed his general surgery residency at The Johns Hopkins Hospital\, and completed a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center. He joined the Division of Surgical Oncology at Moores Cancer Center in 2010. \nDr. Sicklick is an active member of the National Comprehensive Cancer Network (NCCN) Sarcoma and Hepatobiliary Committees\, the Transatlantic Atlantic Retroperitoneal Sarcoma Working Group\, and the SDH GIST Consortium. Dr. Sicklick is on the Editorial Boards of Annals of Surgical Oncology\, Journal of Gastrointestinal Surgery and Journal of Surgical Research. He has published in prestigious journals such as Clinical Cancer Research\, Annals of Surgery\, JAMA Surgery\, Surgery\, and Annals of Surgical Oncology. His translational and clinical research focus on molecular mechanisms of GIST\, as well as precision medicine approaches to cancer therapy. \nThank you to our 2023 Webinar Sponsors!
URL:https://liferaftgroup.org/event/gist-awareness-day-2023-sdh-webinar/
CATEGORIES:Events
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230620T183000
DTEND;TZID=America/New_York:20230620T183000
DTSTAMP:20230601T192629Z
CREATED:20230509T171420Z
LAST-MODIFIED:20230601T192629Z
UID:10000500-1687285800-1687285800@liferaftgroup.org
SUMMARY:GIST Updates from ASCO
DESCRIPTION:ASCO (American Society of Clinical Oncology) is an important conference in the oncology community where new scientific research updates are shared. The Life Raft Group is excited to host Dr. Herbert Loong\, who will summarize abstracts and presentations that were presented during this conference that are relevant to the GIST patient community. \nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\nHerbert H. Loong\, MD\nThe Chinese University of Hong Kong \nDr. Herbert H. Loong holds conjoint appointments of Clinical Associate Professor in the Department of Clinical Oncology and Deputy Medical Director of the Phase 1 Clinical Trials Centre of The Chinese University of Hong Kong. He is also the current and founding convenor of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team. \nDr. Loong obtained his medical degree with a Distinction in Surgery from The University of Hong Kong in 2003. He has completed a Fellowship in Drug Development at Princess Margaret Cancer Centre in Toronto\, Canada with a special focus on Experimental Therapeutics. His clinical and research interests also include Sarcoma Medical Oncology\, Thoracic Oncology and Health Economics. He is a recipient of the European Cancer Congress Fellowship Grant (2013)\, the American Society of Clinical Oncology (ASCO) Annual Meeting Merit Award (2014)\, the Hong Kong College of Physicians Young Investigators’ Award (2014). Nominated by patients and their caregivers\, Dr. Loong led the Lung Cancer Team at CUHK to be bestowed the IASLC Foundation Cancer Care Team Award in recognition for providing the best thoracic oncology care in “Asia & Rest of the World” in 2018. \nDr. Loong has served or continues to serve in various capacities in various professional international oncology bodies\, including the International Affairs Committee and the Asia-Pacific Regional Council of ASCO\, the Membership\, Education and Communications Committees of the IASLC. He has been elected as a Board Member of the Connective Tissue Oncology Society (CTOS) for 2022-2024. He is also a founding executive committee member of the newly formed Asia Pacific Oncology Drug Development Network (APODDC). He is also a Board Member in the specialty of Medical Oncology in the Hong Kong College of Physicians. In his appointment as a Registration Committee member of Pharmacy and Poisons Board of Hong Kong\, he helps oversee the registration of medicinal products and clinical trials in the territory. \nThank you to our 2023 Webinar Sponsors!
URL:https://liferaftgroup.org/event/gist-updates-from-asco/
CATEGORIES:Education,Events
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230519T120000
DTEND;TZID=America/New_York:20230519T130000
DTSTAMP:20230509T171719Z
CREATED:20230424T031643Z
LAST-MODIFIED:20230509T171719Z
UID:10000492-1684497600-1684501200@liferaftgroup.org
SUMMARY:Clinical Trials 101
DESCRIPTION:Dr. Ciara Kelly will be presenting “Clinical Trials 101” to GIST patients and caretakers on May 19th\, 2023 at 12pm ET. During this virtual presentation\, Dr. Kelly will discuss types of clinical trials\, how to find a clinical trial\, current open clinical trials\, and more. \nREGISTERAbout Our Presenter\nDr. Ciara Kelly\,\nMedical Oncologist\, Memorial Sloan Kettering Cancer Center \nDr. Kelly is a medical oncologist at Memorial Sloan Kettering Cancer Center who has expertise in treating and researching bone and soft tissue sarcomas and merkel cell carcinoma. She works very closely with a team of medical oncologists\, surgeons\, radiation oncologists\, nurses\, and patient support advocates. \nDr. Kelly’s research aims to develop new and more personalized therapies to treat sarcomas. She is actively involved in developing and designing clinical trials that will look at novel agents that target molecular changes within tumors. She is also studying innovative combination immunotherapy options that will harness a person’s own immune defenses to fight their cancer. \nDr. Kelly has a particular interest in advancing understanding of gastrointestinal stromal tumors and other sarcomas at the molecular level. She is using liquid biopsies to analyze tumor DNA in the blood and tumor biopsies to uncover a biomarker that will ultimately help match the best treatment option with each individual person’s tumor. Dr. Kelly is committed to designing and developing novel therapeutic clinical trials for GIST patients that incorporate correlative studies which provide an opportunity to further our understanding of this disease. \nThank you to our 2023 Webinar Sponsors!
URL:https://liferaftgroup.org/event/clinical-trials-101/
CATEGORIES:Education,Events
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230502T120000
DTEND;TZID=America/New_York:20230502T130000
DTSTAMP:20230403T163003Z
CREATED:20230403T162300Z
LAST-MODIFIED:20230403T163003Z
UID:10000491-1683028800-1683032400@liferaftgroup.org
SUMMARY:Managing Your Mental Health After Diagnosis
DESCRIPTION:Receiving a cancer diagnosis and undergoing cancer treatment can be a highly stressful and emotionally challenging experience. Patients may experience a range of emotions such as fear\, anxiety\, depression and grief\, as well as many physical symptoms. Paying attention to your mental health is an important part of coping with a cancer diagnosis. The Life Raft Group is partnering with Sarah Paul of CancerCare to host this webinar on May 2nd at 12 ET to discuss why mental health matters and discover ways to find the emotional support that is right for you. \nREGISTERAbout Our Presenter:\nSarah Paul\, LCSW\, OSW-C\nDirector of Clinical Programs\, CancerCare \nMs. Paul is the Director of Clinical Programs and is responsible for delivering CancerCare’s free services to people whose lives are affected by cancer while overseeing administrative aspects of the social work department. Sarah is passionate about creating and developing specialized programs to meet the needs of underserved populations and has a specialization in working with children\, adolescents and young adults. Before starting at CancerCare\, she received her BA in Psychology from SUNY New Paltz and her Master’s in Social Work from Silberman School of Social Work at Hunter College. She is a board certified oncology social worker and in 2020\, she was awarded the Aquamarine Leadership Award by the National Association of Social Workers\, New York City Chapter. \nThank you to our 2023 Webinar Sponsors!
URL:https://liferaftgroup.org/event/managing-mental-health-after-diagnosis/
CATEGORIES:Education,Events
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230316T120000
DTEND;TZID=America/New_York:20230316T120000
DTSTAMP:20230223T133610Z
CREATED:20230222T214046Z
LAST-MODIFIED:20230223T133610Z
UID:10000487-1678968000-1678968000@liferaftgroup.org
SUMMARY:Nutrition Management & Multidisciplinary Approaches in GIST
DESCRIPTION:The Life Raft Group is partnering with Fundación GIST México to present Nutrition Management and Multidisciplinary Approaches in GIST for GIST patients and caretakers on March 16th at 12pm ET.  During this virtual presentation\, Ms. Carbajal-López will describe the onco-nutritional pathway\, effects of malnutrition in GIST\, multidisciplinary approaches to nutrition\, exercise\, and more. \nThere will be time for questions after the presentation. If you would like to submit your questions ahead of time or if you have questions about the presentation\, please email Sara Rothschild: srothschild@liferaftgroup.org \nREGISTERAbout our Presenter:\nBerenice Carbajal-López\nFundación GIST México \nMs. Carbajal-López is a doctoral student who holds a master’s degree in Health Sciences with a thesis related to the use of technologies in the nutritional and psychological care of patients with GIST. She has a diploma in Clinical Research and Biostatistics at the National Cancer Institute in Mexico. She has experience in health care of GIST patients\, as Patient Care Coordinator from 2014 to 2019 and as Global Director since 2020 at Fundación GIST México. Ms. Carbajal-López has also collaborated in drafting and review of research articles and book chapters in the area of Oncology\, with eight publications to date as main author and co-author in indexed journals and has participated in national and international congresses such as SMEO 2018\, ASCO 2019\, and ESMO-GI 2017\, 2018\, 2019\, 2020\, 2021\, and 2022. \nPlease note that this webinar is not a substitute for your physician’s guidance and care.
URL:https://liferaftgroup.org/event/nutrition-management-multidisciplinary-approaches-in-gist/
CATEGORIES:Education,Events
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230208T190000
DTEND;TZID=America/New_York:20230208T190000
DTSTAMP:20221211T172523Z
CREATED:20221209T191343Z
LAST-MODIFIED:20221211T172523Z
UID:10000250-1675882800-1675882800@liferaftgroup.org
SUMMARY:GIST Updates from CTOS
DESCRIPTION:The Life Raft Group is partnering with Dr. Herbert Loong of The Chinese University of Hong Kong to present “GIST Updates from CTOS 2022” to GIST patients and caregivers on February 8th at 7pm ET. During this virtual presentation\, Dr. Loong will discuss scientific updates relevant to GIST patients that were exhibited at the Connective Tissue Oncology Society (CTOS) conference. A Q&A segment will follow Dr. Loong’s presentation. \n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\nHerbert H. Loong\, MD\nThe Chinese University of Hong Kong \nDr. Herbert H. Loong holds conjoint appointments of Clinical Associate Professor in the Department of Clinical Oncology and Deputy Medical Director of the Phase 1 Clinical Trials Centre of The Chinese University of Hong Kong. He is also the current and founding convenor of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team. \nDr. Loong obtained his medical degree with a Distinction in Surgery from The University of Hong Kong in 2003. He has completed a Fellowship in Drug Development at Princess Margaret Cancer Centre in Toronto\, Canada with a special focus on Experimental Therapeutics. His clinical and research interests also include Sarcoma Medical Oncology\, Thoracic Oncology and Health Economics. He is a recipient of the European Cancer Congress Fellowship Grant (2013)\, the American Society of Clinical Oncology (ASCO) Annual Meeting Merit Award (2014)\, the Hong Kong College of Physicians Young Investigators’ Award (2014). Nominated by patients and their caregivers\, Dr. Loong led the Lung Cancer Team at CUHK to be bestowed the IASLC Foundation Cancer Care Team Award in recognition for providing the best thoracic oncology care in “Asia & Rest of the World” in 2018. \nDr. Loong has served or continues to serve in various capacities in various professional international oncology bodies\, including the International Affairs Committee and the Asia-Pacific Regional Council of ASCO\, the Membership\, Education and Communications Committees of the IASLC. He has been elected as a Board Member of the Connective Tissue Oncology Society (CTOS) for 2022-2024. He is also a founding executive committee member of the newly formed Asia Pacific Oncology Drug Development Network (APODDC). He is also a Board Member in the specialty of Medical Oncology in the Hong Kong College of Physicians. In his appointment as a Registration Committee member of Pharmacy and Poisons Board of Hong Kong\, he helps oversee the registration of medicinal products and clinical trials in the territory.
URL:https://liferaftgroup.org/event/gist-updates-from-ctos-2022/
CATEGORIES:Events
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230118T100000
DTEND;TZID=America/New_York:20230118T100000
DTSTAMP:20230103T165747Z
CREATED:20221227T160551Z
LAST-MODIFIED:20230103T165747Z
UID:10000251-1674036000-1674036000@liferaftgroup.org
SUMMARY:La Senda Verde - Virtual Tour
DESCRIPTION:La Senda Verde Tour – January 18 at 10am ET\n \nOur theme for 2023 is Thriving Together and during this time\, we’ll present stories and featured webinars on how our patients & caregivers are thriving living with GIST. We want to celebrate these personal passions and joys with the desire to bring our community their own moments of joy and relaxation through these experiences. \n \nLa Senda Verde co-founders Vicky Ossio & Marcelo Levy \nCaregiver Vicky Ossio shares her passion for rescuing and rehoming animals who were confiscated due to  illegal trafficking and the destruction of their habitats. With co-founder Marcelo Levy\, this sanctuary has sheltered hundreds of displaced animals and worked toward providing a diverse\, natural setting through progressive conservation called rewilding. \nVicky came to know The Life Raft Group through her daughter Carolina\, who was diagnosed with GIST in 2006 at age 27. She and Carolina have attended many Life Fest weekends and GDOLs and have been active volunteers with the LRG throughout the years. \nREGISTERVicky and Marcelo will share a view of Senda Verde to our community on January 18th at 10am. Everyone is welcome to join and enjoy this presentation with a live Q&A to follow. During our tour\, we will meet birds\, reptiles\, monkeys and other big mammals\, like bears and big cats. We will also make a quick visit to our rewinding area to see the native stingless bees\, and our butterfly farm. \nSenda Verde was established in 2003 in the subtropical region east side of the Bolivian Andes in South America. Concerned about the urgent need to do something meaningful in favor of the natural world\, Vicky and Marcelo decided to take hands-on action. They decided to devote their energy\, effort and work to that noble and inspiring task: saving and sheltering wild animals rescued from illegal trafficking and destruction of habitats. \nSenda Verde shelters approximately one thousand wild animals. This sanctuary exists to save and shelter animals rescued from illegal trafficking and destruction of habitats\, and to inspire people to value nature. They have taken a progressive approach to conservation within our property and surrounding areas\, letting natural processes enhance and reshape the land and restore degraded old agricultural landscapes.
URL:https://liferaftgroup.org/event/la-senda-verde-virtual-tour/
CATEGORIES:Events
ATTACH;FMTTYPE=image/jpeg:https://liferaftgroup.org/wp-content/uploads/2022/12/la-senda-verde-event-image.jpg
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
END:VCALENDAR